These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23653455)

  • 21. Glucocorticoids and non-alcoholic fatty liver disease.
    Woods CP; Hazlehurst JM; Tomlinson JW
    J Steroid Biochem Mol Biol; 2015 Nov; 154():94-103. PubMed ID: 26241028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease.
    Leclercq I
    Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and therapy in NASH].
    Tokushige K
    Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
    Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
    Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endocrine obesity].
    Inoue S; Osaka T; Koda M
    Nihon Rinsho; 1995 Jun; 53 Suppl():419-24. PubMed ID: 7563777
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG; Cao HX
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
    Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
    Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-alcoholic fatty liver disease: the mist gradually clears.
    de Alwis NM; Day CP
    J Hepatol; 2008; 48 Suppl 1():S104-12. PubMed ID: 18304679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects.
    Ding WJ; Wang MM; Wang GS; Shen F; Qin JJ; Fan JG
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1753-8. PubMed ID: 25974331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.
    Tokushige K; Hashimoto E; Kodama K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():88-92. PubMed ID: 24251711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is obesity an endocrine condition?
    Stocks AE
    Aust Fam Physician; 1977 Feb; 6(2):109-16. PubMed ID: 558747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.
    Dyson JK; McPherson S; Anstee QM
    J Clin Pathol; 2013 Dec; 66(12):1033-45. PubMed ID: 23940130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.
    Moore JB
    Proc Nutr Soc; 2010 May; 69(2):211-20. PubMed ID: 20158939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and hypothyroidism: a complex relationship in non-alcoholic fatty liver disease.
    Misra S; Singh B
    J Indian Med Assoc; 2013 May; 111(5):324-6, 329. PubMed ID: 24765691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences.
    Del Ben M; Baratta F; Polimeni L; Angelico F
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S291-6. PubMed ID: 23073870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L; Lemoine M
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.